GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Other Long Term Assets

Kineta (STU:J75) Other Long Term Assets : €-0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Other Long Term Assets?

Kineta's other long-term assets for the quarter that ended in Mar. 2024 was €-0.00 Mil.

Kineta's quarterly other long-term assets declined from Sep. 2023 (€0.12 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€-0.00 Mil).

Kineta's annual other long-term assets increased from Dec. 2021 (€0.07 Mil) to Dec. 2022 (€0.12 Mil) but then declined from Dec. 2022 (€0.12 Mil) to Dec. 2023 (€0.00 Mil).


Kineta Other Long Term Assets Historical Data

The historical data trend for Kineta's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Other Long Term Assets Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
0.06 0.07 0.12 -

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.12 0.12 - -

Kineta Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Kineta (STU:J75) Business Description

Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines